Engineered Exosomes-based Theranostic Strategy for Tumor Metastasis and Recurrence

Overview

Journal Asian J Pharm Sci

Date 2024 Jan 1

PMID 38161784

Authors

Min Deng

Shuang Wu

Peizheng Huang

Yun Liu

Chong Li

Ji Zheng

Affiliations

Soon will be listed here.

Abstract

Metastasis-associated processes are the predominant instigator of fatalities linked to cancer, wherein the pivotal role of circulating tumor cells lies in the resurgence of malignant growth. In recent epochs, exosomes, constituents of the extracellular vesicle cohort, have garnered attention within the field of tumor theranostics owing to their inherent attributes encompassing biocompatibility, modifiability, payload capacity, stability, and therapeutic suitability. Nonetheless, the rudimentary functionalities and limited efficacy of unmodified exosomes curtail their prospective utility. In an effort to surmount these shortcomings, intricate methodologies amalgamating nanotechnology with genetic manipulation, chemotherapy, immunotherapy, and optical intervention present themselves as enhanced avenues to surveil and intercede in tumor metastasis and relapse. This review delves into the manifold techniques currently employed to engineer exosomes, with a specific focus on elucidating the interplay between exosomes and the metastatic cascade, alongside the implementation of tailored exosomes in abating tumor metastasis and recurrence. This review not only advances comprehension of the evolving landscape within this domain but also steers the trajectory of forthcoming investigations.

Citing Articles

Identification of potential biomarkers for lung cancer using integrated bioinformatics and machine learning approaches.

Rabby M, Islam M, Kumar S, Maniruzzaman M, Hasan M, Tomioka Y PLoS One. 2025; 20(2):e0317296.

PMID: 40014586 PMC: 11867339. DOI: 10.1371/journal.pone.0317296.

Subcellular Organelle Targeting as a Novel Approach to Combat Tumor Metastasis.

Liu Z, Liu Y, Kang X, Li L, Xiang Y Pharmaceutics. 2025; 17(2).

PMID: 40006565 PMC: 11859411. DOI: 10.3390/pharmaceutics17020198.

Advances in drug delivery systems utilizing blood cells and their membrane-derived microvesicles.

He A, Huang Y, Cao C, Li X Drug Deliv. 2024; 31(1):2425156.

PMID: 39520082 PMC: 11552282. DOI: 10.1080/10717544.2024.2425156.

Stem Cell-Derived Exosomes: Natural Intercellular Messengers with Versatile Mechanisms for the Treatment of Diabetic Retinopathy.

Song Y, Yin C, Kong N Int J Nanomedicine. 2024; 19:10767-10784.

PMID: 39469447 PMC: 11514697. DOI: 10.2147/IJN.S475234.

Delivery of miRNAs Using Nanoparticles for the Treatment of Osteosarcoma.

Wang C, Zhang Y, Kong W, Rong X, Zhong Z, Jiang L Int J Nanomedicine. 2024; 19:8641-8660.

PMID: 39188861 PMC: 11346496. DOI: 10.2147/IJN.S471900.

References

de Jong W, Borm P . Drug delivery and nanoparticles:applications and hazards. Int J Nanomedicine. 2008; 3(2):133-49. PMC: 2527668. DOI: 10.2147/ijn.s596. View

Zhang H, Wang Y, Li M, Cao K, Qi Z, Zhu L . A self-guidance biological hybrid drug delivery system driven by anaerobes to inhibit the proliferation and metastasis of colon cancer. Asian J Pharm Sci. 2023; 17(6):892-907. PMC: 9800957. DOI: 10.1016/j.ajps.2022.09.003. View

Boire A, Brastianos P, Garzia L, Valiente M . Brain metastasis. Nat Rev Cancer. 2019; 20(1):4-11. DOI: 10.1038/s41568-019-0220-y. View

Cianciaruso C, Beltraminelli T, Duval F, Nassiri S, Hamelin R, Mozes A . Molecular Profiling and Functional Analysis of Macrophage-Derived Tumor Extracellular Vesicles. Cell Rep. 2019; 27(10):3062-3080.e11. PMC: 6581796. DOI: 10.1016/j.celrep.2019.05.008. View

Luga V, Zhang L, Viloria-Petit A, Ogunjimi A, Inanlou M, Chiu E . Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell. 2012; 151(7):1542-56. DOI: 10.1016/j.cell.2012.11.024. View

Chen J, Song Y, Miao F, Chen G, Zhu Y, Wu N . PDL1-positive exosomes suppress antitumor immunity by inducing tumor-specific CD8 T cell exhaustion during metastasis. Cancer Sci. 2021; 112(9):3437-3454. PMC: 8409314. DOI: 10.1111/cas.15033. View

Di H, Zeng E, Zhang P, Liu X, Zhang C, Yang J . General Approach to Engineering Extracellular Vesicles for Biomedical Analysis. Anal Chem. 2019; 91(20):12752-12759. DOI: 10.1021/acs.analchem.9b02268. View

Adem B, Vieira P, Melo S . Decoding the Biology of Exosomes in Metastasis. Trends Cancer. 2020; 6(1):20-30. DOI: 10.1016/j.trecan.2019.11.007. View

Maas S, Breakefield X, Weaver A . Extracellular Vesicles: Unique Intercellular Delivery Vehicles. Trends Cell Biol. 2016; 27(3):172-188. PMC: 5318253. DOI: 10.1016/j.tcb.2016.11.003. View

10.

Dou R, Liu K, Yang C, Zheng J, Shi D, Lin X . EMT-cancer cells-derived exosomal miR-27b-3p promotes circulating tumour cells-mediated metastasis by modulating vascular permeability in colorectal cancer. Clin Transl Med. 2021; 11(12):e595. PMC: 8694332. DOI: 10.1002/ctm2.595. View

11.

Xu X, Liang Y, Li X, Ouyang K, Wang M, Cao T . Exosome-mediated delivery of kartogenin for chondrogenesis of synovial fluid-derived mesenchymal stem cells and cartilage regeneration. Biomaterials. 2020; 269:120539. DOI: 10.1016/j.biomaterials.2020.120539. View

12.

Ma G, Lin W . Immune checkpoint inhibition mediated with liposomal nanomedicine for cancer therapy. Mil Med Res. 2023; 10(1):20. PMC: 10142459. DOI: 10.1186/s40779-023-00455-x. View

13.

Liu C, Kelnar K, Liu B, Chen X, Calhoun-Davis T, Li H . The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med. 2011; 17(2):211-5. PMC: 3076220. DOI: 10.1038/nm.2284. View

14.

Cai Z, Yang F, Yu L, Yu Z, Jiang L, Wang Q . Activated T cell exosomes promote tumor invasion via Fas signaling pathway. J Immunol. 2012; 188(12):5954-61. DOI: 10.4049/jimmunol.1103466. View

15.

Buck A, Coakley G, Simbari F, McSorley H, Quintana J, Le Bihan T . Exosomes secreted by nematode parasites transfer small RNAs to mammalian cells and modulate innate immunity. Nat Commun. 2014; 5:5488. PMC: 4263141. DOI: 10.1038/ncomms6488. View

16.

Chen L, Guo P, He Y, Chen Z, Chen L, Luo Y . HCC-derived exosomes elicit HCC progression and recurrence by epithelial-mesenchymal transition through MAPK/ERK signalling pathway. Cell Death Dis. 2018; 9(5):513. PMC: 5938707. DOI: 10.1038/s41419-018-0534-9. View

17.

Zhang M, Hu S, Liu L, Dang P, Liu Y, Sun Z . Engineered exosomes from different sources for cancer-targeted therapy. Signal Transduct Target Ther. 2023; 8(1):124. PMC: 10017761. DOI: 10.1038/s41392-023-01382-y. View

18.

Yang S, Ma S, Dou H, Liu F, Zhang S, Jiang C . Breast cancer-derived exosomes regulate cell invasion and metastasis in breast cancer via miR-146a to activate cancer associated fibroblasts in tumor microenvironment. Exp Cell Res. 2020; 391(2):111983. DOI: 10.1016/j.yexcr.2020.111983. View

19.

Lee D, Gardner R, Porter D, Louis C, Ahmed N, Jensen M . Current concepts in the diagnosis and management of cytokine release syndrome. Blood. 2014; 124(2):188-95. PMC: 4093680. DOI: 10.1182/blood-2014-05-552729. View

20.

Hao S, Yu J, He W, Huang Q, Zhao Y, Liang B . Cysteine Dioxygenase 1 Mediates Erastin-Induced Ferroptosis in Human Gastric Cancer Cells. Neoplasia. 2017; 19(12):1022-1032. PMC: 5686465. DOI: 10.1016/j.neo.2017.10.005. View